Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Hepatitis B core-related antigen to detect hepatitis B virus (HBV) reactivation in heart transplant recipients with past HBV infection: A pilot study.

Iossa D, Vitrone M, Liotti A, Portella G, Durante-Mangoni E, Zampino R.

Clin Transplant. 2019 Apr 23:e13574. doi: 10.1111/ctr.13574. [Epub ahead of print]

PMID:
31013373
2.

Dynamics and management of oral anticoagulant treatment in chronic hepatitis C patients undergoing therapy with direct antiviral agents.

Vitrone M, Parrella A, Albisinni R, Durante-Mangoni E, Zampino R.

J Chemother. 2019 Apr;31(2):86-89. doi: 10.1080/1120009X.2019.1571661. Epub 2019 Feb 20.

PMID:
30784359
3.

Liver histopathological findings in advanced heart failure: a reappraisal of cardiac cirrhosis concept.

Durante-Mangoni E, Parrella A, Pafundi PC, Vitrone M, Ragone E, De Rosa I, Amarelli C, Zampino R.

Intern Emerg Med. 2019 Jan 28. doi: 10.1007/s11739-019-02033-3. [Epub ahead of print]

PMID:
30689135
4.

Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12.

Pisaturo M, Minichini C, Starace M, Caroprese M, Macera M, Brancaccio G, De Pascalis S, Santonicola A, Galeota Lanza A, Zampino R, Cotticelli G, Sagnelli E, Gaeta GB, Coppola N.

Liver Int. 2019 May;39(5):844-853. doi: 10.1111/liv.14025. Epub 2019 Jan 4.

PMID:
30554459
5.

Treatment outcomes of colistin and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial.

Dickstein Y, Lellouche J, Dalak Amar MB, Schwartz D, Nutman A, Daitch V, Yahav D, Leibovici L, Skiada A, Antoniadou A, Daikos GL, Andini R, Zampino R, Durante-Mangoni E, Mouton JW, Friberg LE, Benattar YD, Bitterman R, Neuberger A, Carmeli Y, Paul M; AIDA study group.

Clin Infect Dis. 2018 Nov 20. doi: 10.1093/cid/ciy988. [Epub ahead of print]

PMID:
30462182
6.

No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis.

Zampino R, Macera M, Cirillo G, Pafundi PC, Rinaldi L, Coppola N, Pisaturo M, Adinolfi LE, Miraglia Del Giudice E, Ingrosso D, Capasso R.

Infez Med. 2018 Sep 1;26(3):244-248.

7.

Effect of a Cooperation Strategy between Primary Care Physicians and Hospital Liver Units on HBV Care in Campania, Italy.

Zampino R, Capoluongo N, Boemio A, Macera M, Vitrone M, Adinolfi LE, Filippini P, Sagnelli E, Sagnelli C, Durante-Mangoni E, Coppola N.

Can J Gastroenterol Hepatol. 2018 Jul 26;2018:5670374. doi: 10.1155/2018/5670374. eCollection 2018.

8.

Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress.

Zampino R, Marrone A, Rinaldi L, Guerrera B, Nevola R, Boemio A, Iuliano N, Giordano M, Passariello N, Sasso FC, Albano E, Adinolfi LE.

Infection. 2018 Dec;46(6):793-799. doi: 10.1007/s15010-018-1185-6. Epub 2018 Jul 31.

PMID:
30066228
9.

The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.

Zak-Doron Y, Dishon Benattar Y, Pfeffer I, Daikos GL, Skiada A, Antoniadou A, Durante-Mangoni E, Andini R, Cavezza G, Leibovici L, Yahav D, Eliakim-Raz N, Carmeli Y, Nutman A, Paul M; AIDA Study Group .

Clin Infect Dis. 2018 Nov 28;67(12):1815-1823. doi: 10.1093/cid/ciy371.

PMID:
29718143
10.

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.

Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Pafundi PC, Adler A, Dickstein Y, Pavleas I, Zampino R, Daitch V, Bitterman R, Zayyad H, Koppel F, Levi I, Babich T, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L.

Lancet Infect Dis. 2018 Apr;18(4):391-400. doi: 10.1016/S1473-3099(18)30099-9. Epub 2018 Feb 16.

PMID:
29456043
11.

The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.

Zampino R, Lebano R, Coppola N, Macera M, Grandone A, Rinaldi L, De Sio I, Tufano A, Stornaiuolo G, Adinolfi LE, Durante-Mangoni E, Battista GG, Niglio A.

Saudi J Gastroenterol. 2018 Jan-Feb;24(1):25-29. doi: 10.4103/sjg.SJG_100_17.

12.

Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.

Rinaldi L, Ascione A, Messina V, Rosato V, Valente G, Sangiovanni V, Zampino R, Marrone A, Fontanella L, de Rosa N, Orabona P, Buonomo C, Chirianni A, Adinolfi LE, Piai G.

Infection. 2018 Apr;46(2):231-238. doi: 10.1007/s15010-017-1113-1. Epub 2018 Jan 15.

PMID:
29335905
13.

Virological patterns of HCV patients with failure to interferon-free regimens.

Starace M, Minichini C, De Pascalis S, Macera M, Occhiello L, Messina V, Sangiovanni V, Adinolfi LE, Claar E, Precone D, Stornaiuolo G, Stanzione M, Ascione T, Caroprese M, Zampino R, Parrilli G, Gentile I, Brancaccio G, Iovinella V, Martini S, Masarone M, Fontanella L, Masiello A, Sagnelli E, Punzi R, Salomone Megna A, Santoro R, Gaeta GB, Coppola N.

J Med Virol. 2018 May;90(5):942-950. doi: 10.1002/jmv.25022. Epub 2018 Feb 1.

PMID:
29315640
14.

Direct antiviral treatment of chronic hepatitis C in heart transplant recipients.

Vitrone M, Andini R, Mattucci I, Maiello C, Atripaldi L, Durante-Mangoni E, Zampino R.

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12813. Epub 2017 Dec 21.

PMID:
29139181
15.

Hepatitis B virus reactivation after heart transplant: Incidence and clinical impact.

Vitrone M, Iossa D, Rinaldi L, Pafundi PC, Molaro R, Parrella A, Andini R, Ragone E, Maiello C, Zampino R, Durante-Mangoni E.

J Clin Virol. 2017 Nov;96:54-59. doi: 10.1016/j.jcv.2017.09.011. Epub 2017 Sep 23.

PMID:
28964958
16.

Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases.

Zampino R, Vitrone M, Parrella A, Ragone E, Durante-Mangoni E.

J Chemother. 2018 Apr;30(2):129-130. doi: 10.1080/1120009X.2017.1376782. Epub 2017 Sep 19.

PMID:
28925824
17.

Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.

Rinaldi L, Nascimbeni F, Giordano M, Masetti C, Guerrera B, Amelia A, Fascione MC, Ballestri S, Romagnoli D, Zampino R, Nevola R, Baldelli E, Iuliano N, Rosato V, Lonardo A, Adinolfi LE.

World J Gastroenterol. 2017 Feb 28;23(8):1458-1468. doi: 10.3748/wjg.v23.i8.1458.

18.

ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens.

Coppola N, De Pascalis S, Messina V, Di Caprio G, Martini S, de Stefano G, Starace M, Stornaiuolo G, Stanzione M, Ascione T, Minichini C, Sangiovanni V, Zampino R, Calò F, Rinaldi L, Persico M, Federico A, Buonomo AR, Borgia G, Gaeta GB, Filippini P, Gentile I.

Antivir Ther. 2017;22(7):551-558. doi: 10.3851/IMP3134. Epub 2017 Feb 6.

PMID:
28165327
19.

Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study.

Ruggiero G, Marrone A, Rainone I, Boemio A, Adinolfi LE, Pasquale G, Rinaldi L, Guerrera B, Andreana L, Zampino R; Thecla Study Group.

Infez Med. 2016 Dec 1;24(4):278-286.

20.

CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection.

Coppola N, Zampino R, Bellini G, Stanzione M, Capoluongo N, Marrone A, Macera M, Adinolfi LE, Giudice EM, Gentile I, Sagnelli E, Rossi F.

Dig Liver Dis. 2016 Nov;48(11):1364-1369. doi: 10.1016/j.dld.2016.07.005. Epub 2016 Jul 15.

PMID:
27476469

Supplemental Content

Loading ...
Support Center